On 11 November 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 150,000 A shares, representing approximately 0.0024% of the previously issued shares (excluding treasury shares). The highest repurchase price per share reached RMB 61.07, and the lowest was RMB 61.01, resulting in a total payment of RMB 9,152,600.
After the repurchase, the number of shares (excluding treasury shares) decreased from 6,375,873,264 to 6,375,723,264. Treasury shares increased from 3,129,010 to 3,279,010, while the total number of issued shares remained at 6,379,002,274.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.